Showing 25–36 of 114 results

ERLI PLUS XR 25/1000 TAB

735.00
Metformin hydrochloride is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes mellitus, lowering both basal

ERLI PLUS XR 5/1000 TAB

406.00
Metformin hydrochloride is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes mellitus, lowering both basal

ERLI TAB 10MG

405.00
Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the

ERLI TAB 25MG

588.00
Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the

EVOPRIDE 1/500MG TAB

286.00
<h6>Glimepiride: Glimepiride is a third generation sulphonylurea. The primary mechanism of action of glimepiride appears to be dependent on stimulating

EVOPRIDE 2/500MG TAB

448.00
<h6>Glimepiride: Glimepiride is a third generation sulphonylurea. The primary mechanism of action of glimepiride appears to be dependent on stimulating

EVOPRIDE 2MG TAB

455.00
<h6>The primary mechanism of action of glimepiride in lowering blood glucose is by stimulating pancreatic beta cells to produce more

EVOPRIDE 3MG TAB

570.00
<h6>The primary mechanism of action of glimepiride in lowering blood glucose is by stimulating pancreatic beta cells to produce more

EVOPRIDE 4MG TAB.

850.00
<h6>The primary mechanism of action of glimepiride in lowering blood glucose is by stimulating pancreatic beta cells to produce more

GETRYL 1MG TAB

110.26
The primary mechanism of action of glimepiride in lowering blood glucose is by stimulating pancreatic beta cells to produce more

GETRYL 2MG TAB

523.00
It is used to help individuals with type II diabetes control their blood sugar levels. There could be nausea and

GETRYL 3MG TAB

717.00
The primary mechanism of action of glimepiride in lowering blood glucose is by stimulating pancreatic beta cells to produce more